Skip to main content
CARR'S GROUP PLC logo

CARR'S GROUP PLC — Investor Relations & Filings

Ticker · CARR ISIN · GB00BRK01058 LEI · 213800HTIKPQV98RA653 IL Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2018-11-30 Director's Dealing
Country GB United Kingdom
Listing IL CARR

About CARR'S GROUP PLC

https://www.carrsgroup.com/

Fevara plc, formerly Carr's Group PLC, is an international specialist in livestock supplements. The company develops, manufactures, and markets a range of research-proven nutritional products for pasture-based livestock, primarily cattle, sheep, and horses. Its portfolio includes branded feed licks, blocks, bagged minerals, and boluses designed to boost profitability, improve resource efficiency, and support sustainable agriculture for farmers with extensive grazing systems. The company's products are sold globally under recognized brands including Crystalyx, Horslyx, Scotmin Nutrition, Smartlic, and Tracesure.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is clearly identified as an 'RNS Number' filing from Carr's Group PLC, dated November 30, 2018. The content details share transactions (sale and purchase) involving the Non-Executive Chairman (Chris Holmes) and his wife, which falls under the definition of insider trading or director/PDMR shareholding disclosure. This specific type of regulatory disclosure, especially when originating from the London Stock Exchange's RNS service, is best classified as Director's Dealing (DIRS). Although RNS is a general category, DIRS is more specific for this content type.
2018-11-30 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1698 chars) and is explicitly marked with an 'RNS Number' and states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content details the 'Total Voting Rights' as of November 30, 2018, referencing the FCA's Disclosure and Transparency Rule 5.6.1. This type of mandatory, brief regulatory update that doesn't fit a specific financial report category (like 10-K or ER) is best classified as a general Regulatory Filing (RNS). It is not an announcement of a report (RPA), nor is it about dividends (DIV), director dealings (DIRS), or capital changes (SHA), although it relates to share structure, its primary purpose is regulatory disclosure.
2018-11-30 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the RNS Number (5399I) and explicitly mentions 'Director/PDMR Shareholdings'. It details the exercise of options and subsequent sale of shares by key executives (CEO, Group Finance Director, Head of Group Finance). This content directly corresponds to the reporting requirements for insider transactions by persons discharging managerial responsibilities (PDMRs) under market abuse regulations. This aligns perfectly with the definition for Director's Dealing (DIRS).
2018-11-26 English
Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing information via 'RNS, the news service of the London Stock Exchange'. The content details the granting of share options (Awards) to PDMRs (Persons Discharging Managerial Responsibilities) and includes required disclosures under Article 19(3) of the Market Abuse Regulation. This type of mandatory disclosure regarding insider transactions (Director/PDMR Shareholdings) is a specific regulatory filing. While it relates to insider trading (which might suggest DIRS), the format and source (RNS) strongly point to a general regulatory announcement. Since 'Director's Dealing' (DIRS) is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this document details the *grant* of options to executives, DIRS is the most specific fit among the provided options for insider transaction reporting. If DIRS were not available, RNS would be the fallback, but DIRS covers this specific activity.
2018-11-19 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1501 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, short-form operational announcement related to trading mechanisms. This type of brief, regulatory-mandated operational update that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing (RNS), as per the definition and the presence of the RNS identifier.
2018-11-12 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1484 characters) and contains an RNS Number, indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' for a security, which is a routine operational notice related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate fallback category is Regulatory Filings (RNS).
2018-11-12 English

Browse filings by year

47 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.